https://carrerasresearch.org/ca/publicacions/an-open-label-phase-2-study-treating-patients-with-first-or-second-relapse-of-multiple-myeloma-with-carfilzomib-pomalidomide-and-dexamethasone-kpd:-select-study/
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study